|VOLUME 3, ISSUE 1 - SPRING 2009 |
In the Journal of Global Drug Policy and Practice, our authors have presented insights that illumine the many aspects of the international drug problem. At this juncture in our world political history, the editors asked for their contributions to a special edition.
Some of our experts, coming from many different fields and representing many different nations, addressed new or re-elected world leaders in our Winter 2009 edition. They each presented a unique perspective on drug treatment, policy or prevention and gave advice about the most critical issues in the drug arena.
This issue focuses on a troubling and increasingly widespread problem – controlling prescription drug abuse. Its complexity requires a more in-depth examination and a longer treatment; hence, the editors decided to include both parts of a two part series in one issue. In our commentary piece, Dr. Robert DuPont reviews the current administration’s approach to medical marijuana.
The Journal of Global Drug Policy and Practice, a joint effort of the Institute on Global Drug Policy and the International Scientific and Medical Forum on Drug Abuse, is an international, open access, peer-reviewed, online journal with the goal of bridging the information gap on drug policy issues between the medical/scientific community, policymakers and the concerned lay public.
Edited by Eric A. Voth, MD, FACP and David A. Gross, MD, DFAPA, our intended readership includes clinicians, clinical researchers, policymakers, prevention specialists and the interested public.